A Randomized Controlled Clinical Trial of Corneal Epithelial Autograft for Pterygium
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 45
- 试验地点
- 1
- 主要终点
- Restoration of corneal surface
研究概览
简要总结
The purpose of the study is to explore whether femtosecond laser-assisted cornea epithelial autograft is more effective than limbal conjunctival autograft for ocular surface reconstruction after excision of pterygium.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age between 18 to 80 years old;
- •Primary pterygium, scheduled for elective surgical excision;
- •Pterygium encroaching from the nasal side onto the cornea, with less than 180° limbal involvement and without approaching the central visual axis (pupil area);
- •Morphologically intact palisades of Vogt in a given limbal region;
- •Absence of any one of the following structures in the limbal region underneath the pterygium: (1) epithelial basal cells with dark cytoplasm and reflective cell borders; (2) at least two prominent palisade ridge structures; (3) at least one circular and/or oval-shaped focal stromal projection;
- •Informed consent signed by patient or legal guardian; Having the ability to comply with study assessments for the full duration of the study.
排除标准
- •Limbal stem cell deficiency by ocular surface disorders other than pterygium;
- •Inability to determine whether the palisades of Vogt underneath the pterygium is absent or not using in vivo confocal microscopy;
- •High myopia with a spherical equivalent of -15.0 D or less;
- •Corneal or ocular surface infection within 30 days prior to study entry;
- •Ocular surface malignancy;
- •Uncontrolled diabetes with most recent Hemoglobin A1c greater than 8.5%;
- •Renal failure with creatinine clearance< 25ml/min;
- •Alanine aminotransferase > 40IU/L, or aspartate aminotransferase > 40IU/L;
- •Platelet levels < 150,000 or > 450,000 per microliter;
- •Hemoglobin < 12.0 g/dL (male) or < 11.0 g/dL (female);
- •Prothrombin time > 16s and activated partial thrombin time > 35s in patients not accepting anticoagulant therapy; An international normalized ratio greater than 3 in patients accepting anticoagulant therapy;
- •Pregnancy (positive test) or lactation;
- •Participation in another simultaneous medical investigation or clinical trial;
- •Severe cicatricial eye disease;
- •Ocular comorbidities that affect the prognosis of transplantation, such as advanced glaucoma or retinal diseases;
- •Severe dry eye disease as determined by Schirmer's test < 2mm at least in one eye;
- •Any medical or social condition that in the judgement of the investigator would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent;
- •Signs of current infection, including fever and treatment with antibiotics;
- •Active immunological diseases;
- •History of allo-limbal transplantation, penetrating keratoplasty or anti-glaucoma filtering surgeries.
研究组 & 干预措施
Corneal epithelial autograft
pterygium resection combined with femtosecond laser assisted corneal epithelial autograft
干预措施: Corneal epithelial autograft (Procedure)
Corneal epithelial autograft
pterygium resection combined with femtosecond laser assisted corneal epithelial autograft
干预措施: Femtosecond laser (Device)
Limbal conjunctival autograft
pterygium resection combined with diamond knife assisted limbal conjunctival autograft
干预措施: Limbal conjunctival autograft (Procedure)
Limbal conjunctival autograft
pterygium resection combined with diamond knife assisted limbal conjunctival autograft
干预措施: Diamond knife (Device)
Simple removal
Simple removal of pterygium
干预措施: Simple removal (Procedure)
结局指标
主要结局
Restoration of corneal surface
时间窗: 1 year
Restoration of a completely epithelized, stable, and avascular corneal surface
次要结局
- Reconstruction of palisades of Vogt(1 year)
- Corneal haze measurement(1 year)
- Recurrence of pterygium(1 year)
- Best corrected visual acuity(1 year)
- Corneal power and astigmatism(1 year)
研究者
Chunxiao Wang
Clinical investigator
Sun Yat-sen University
